2021-02978. Importer of Controlled Substances Application: Sigma Aldrich Co., LLC.  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Sigma Aldrich Co. LLC. has applied to be registered as an importer Start Printed Page 9538of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 18, 2021. Such persons may also file a written request for a hearing on the application on or before March 18, 2021.

    ADDRESSES:

    Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.34(a), this is notice that on January 15, 2021, Sigma Aldrich Co., LLC, 3500 Dekalb Street, Saint Louis, Missouri 63118-4103, applied to be registered as an importer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Cathinone1235I
    Methcathinone1237I
    Mephedrone (4-Methyl-N-methylcathinone)1248I
    Gamma Hydroxybutyric Acid2010I
    Tetrahydrocannabinols7370I
    4-Bromo-2,5-dimethoxyamphetamine7391I
    4-Bromo-2,5-dimethoxyphenethylamine7392I
    2,5-Dimethoxyamphetamine7396I
    3,4-Methylenedioxyamphetamine7400I
    3,4-Methylenedioxy-N-ethylamphetamine7404I
    3,4-Methylenedioxymethamphetamine7405I
    4-Methoxyamphetamine7411I
    Dimethyltryptamine7435I
    N-Benzylpiperazine7493I
    Heroin9200I
    Normorphine9313I
    Amobarbital2125II
    Secobarbital2315II
    Nabilone7379II
    Phencyclidine7471II
    Ecgonine9180II
    Ethylmorphine9190II
    Levorphanol9220II
    Meperidine9230II
    Thebaine9333II
    Opium, powdered9639II
    Levo-alphacetylmethadol9648II

    The company plans to import the listed controlled substances for sale to research facilities for drug testing and analysis. In reference to drug code 7370 (Tetrahydrocannabinols) the company plans to import synthetic Tetrahydrocannabinols. No other activity for this drug code is authorized for this registration.

    Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

    Start Signature

    William T. McDermott,

    Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2021-02978 Filed 2-12-21; 8:45 am]

    BILLING CODE P

Document Information

Published:
02/16/2021
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2021-02978
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 18, 2021. Such persons may also file a written request for a hearing on the application on or before March 18, 2021.
Pages:
9537-9538 (2 pages)
Docket Numbers:
Docket No. DEA-787
PDF File:
2021-02978.pdf